WWTR1 and non-small cell lung carcinoma: Additionally, Zhou et al (27) reported that TAZ is overexpressed in non-small-cell lung carcinoma (NSCLC), and knockdown of TAZ significantly impaired the tumorigenic ability of the NSCLC cells.